A prospective risk-stratified follow-up programme for radically treated renal cell carcinoma patients: evaluation after eight years of clinical use

Limited use of surveillance imaging following nephrectomy for renal cell carcinoma

(2016) Eric H. Kim et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Patterns of surveillance imaging after nephrectomy in the Medicare population

(2015) Michael A. Feuerstein et al.   BJU INTERNATIONAL

Evaluation of the National Comprehensive Cancer Network and American Urological Association Renal Cell Carcinoma Surveillance Guidelines

(2014) Suzanne B. Stewart et al.   JOURNAL OF CLINICAL ONCOLOGY

The blind spots in follow-up after nephrectomy or nephron-sparing surgery for localized renal cell carcinoma

(2014) Tim J. van Oostenbrugge et al.   WORLD JOURNAL OF UROLOGY

Contemporary external validation of the Leibovich model for prediction of progression after radical surgery for clear cell renal cell carcinoma

(2014) Christian Beisland et al.   Scandinavian Journal of Urology

External validation of a Cox prognostic model: principles and methods

(2013) Patrick Royston et al.   BMC Medical Research Methodology

Incidentally detected renal cell carcinomas are highly associated with comorbidity and mortality unrelated to renal cell carcinoma

(2013) KRISTOFFER E. SAND et al.   Scandinavian Journal of Urology

External Validation of the Leibovich Prognosis Score for Nonmetastatic Clear Cell Renal Cell Carcinoma at a Single European Center Applying Routine Pathology

(2011) Martin Pichler et al.   JOURNAL OF UROLOGY

Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter Study

(2009) Daniel Y.C. Heng et al.   JOURNAL OF CLINICAL ONCOLOGY

Validation by calibration of the UCLA integrated staging system prognostic model for nonmetastatic renal cell carcinoma after nephrectomy

(2008) Luca Cindolo et al.   CANCER

External Validation of the Mayo Clinic Stage, Size, Grade, and Necrosis (SSIGN) Score for Clear-Cell Renal Cell Carcinoma in a Single European Centre Applying Routine Pathology

(2008) Richard Zigeuner et al.   EUROPEAN UROLOGY